The Estrogen‐receptor and/or progesterone receptor expressing cells are classified as ER/PR positive breast cancer, Human Epidermal Growth Factor Receptor 2 (HER2) positive or the subtype that does not express any of these receptors, termed Triple Negative Breast Cancer. Here, ERBB2 is linked to breast cancer.